94292-84-9

Basic information

• Product Name: (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid
• Synonyms: (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid
• CAS NO: 94292-84-9
• Molecular Weight: 352.471
• Mol File: 94292-84-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid(94292-84-9)
• EPA Substance Registry System: (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid(94292-84-9)

Safety Data

• Hazardous Substances Data: 94292-84-9(Hazardous Substances Data)

Upstream product

• 91842-14-7 (S,E)-((1-bromooct-1-en-3-yl)oxy)(tert-butyl)dimethylsilane 
• 50999-83-2 (S)-tert-butyl-(1-ethynylhexyloxy)dimethylsilane 
• 97514-88-0 [2(E)-5-(trimethylsilyl)pent-2-en-4-ynyl]triphenylphosphonium bromide 
• 32556-71-1 1-octyn-3-ol 
• 35042-52-5 (E)-2-penten-4-yn-1-ol 
• 94292-98-5 4-[(4S,5S)-5-((1E,3E,5E,7E)-(S)-9-Hydroxy-tetradeca-1,3,5,7-tetraenyl)-2-oxo-[1,3]dioxolan-4-yl]-butyric acid ethyl ester 
• 99095-27-9 (7E,9E,11E,13E)-(5S,6S,15S)-5,6,15-Trihydroxy-icosa-7,9,11,13-tetraenoic acid methyl ester 
• 94235-42-4 epi-lipoxin A₄ 
• 114144-28-4 5S-hydroxy-14,15-LTA₄ 
• 94235-42-4 4-[(2S,3S)-3-((1E,3E,5Z,7E)-(R)-9-Hydroxy-tetradeca-1,3,5,7-tetraenyl)-oxiranyl]-butyric acid 
• 506-32-1 all cis 5,8,11,14-eicosatetraenoic acid 
• 94235-41-3 4-[(2R,3R)-3-((1E,3E,5E,7E)-(S)-9-Hydroxy-tetradeca-1,3,5,7-tetraenyl)-oxiranyl]-butyric acid ethyl ester 
• 94292-93-0 4-[(4S,5S)-2-Oxo-5-((1E,3E)-5-oxo-penta-1,3-dienyl)-[1,3]dioxolan-4-yl]-butyric acid ethyl ester 
• 99017-13-7 (7E,9E,13E)-(5S,6S,15S)-5,6,15-Tris-(tert-butyl-dimethyl-silanyloxy)-icosa-7,9,13-trien-11-ynoic acid methyl ester 

Relevant articles and documents

SYNTHESIS OF 5S-HYDROXY-14,15 LTA4 A BIOGENIC PRECURSOR TO THE LIPOXINS

A synthesis of 5S-hydroxy-14,15-LTA4 10 an intermediate in the biosynthesis of the lipoxins is described.

Stereocontrolled Total Synthesis of Lipoxins A

A stereocontrolled total synthesis of lipoxin A and a number of its isomers is reported.The strategy involves Sharpless asymmetric epoxidation and pinylborane asymmetric reduction to build the hydroxy-bearing stereocenters and a Wittig-type as well as a P

SYNTHESIS OF LIPOXINS: TOTAL SYNTHESIS OF CONJUGATED TRIHYDROXY EICOSATETRAENOIC ACIDS

The first synthesis of a conjugated trihydroxy eicosatetraenoic acid, a possible structure for Lipoxin A is described.A biomimetic approach was utilized.